zurück Home

Nieren - Karzinom: Prognose

UICC-Stadium

blauer Punkt Stadium 5a-Überleben
blauer Punkt I 95%
blauer Punkt II 89%
blauer Punkt III 60%
blauer Punkt IV 25%
mRCC metastasiertes Nierenzellkarzinom
blauer Punkt Motzer - Hudes - Kriterien
blauer Punkt
  • Intervall < 1 Jahr
  • Metastasen in mehreren Organen
  • KI < 80
  • Anämie
  • LDH > 1,5 x Normalwert
  • Serum-Ca > 10mg/dl
 max 1 Kriterium: Survival 2 Jahre - low risk
> 2 Kriterien: Survival 4 - 8 Monate - high risk
Quellen 1.) Motzer RJ, Mazumdar M, Bacik J, et al:
Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.
J Clin Oncol 1999;17:2530-2540

2.)Motzer RJ, Bacik J, Murphy BA, et al:
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma.
J Clin Oncol 2002;20:289-296

3.) Mekhail TM, Abou-Jawde RM, Boumerhi G, et al.
Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma.
J Clin Oncol 2005;23:832-41.

Impressum                           Zuletzt geändert am 06.06.2022 8:18